MX10146A - Procedimiento para la produccion de preparados medicinales que contienen y liberan sustancias activas y producto obtenido. - Google Patents

Procedimiento para la produccion de preparados medicinales que contienen y liberan sustancias activas y producto obtenido.

Info

Publication number
MX10146A
MX10146A MX1014688A MX1014688A MX10146A MX 10146 A MX10146 A MX 10146A MX 1014688 A MX1014688 A MX 1014688A MX 1014688 A MX1014688 A MX 1014688A MX 10146 A MX10146 A MX 10146A
Authority
MX
Mexico
Prior art keywords
procedure
contain
production
product obtained
active substances
Prior art date
Application number
MX1014688A
Other languages
English (en)
Inventor
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of MX10146A publication Critical patent/MX10146A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX1014688A 1987-01-21 1988-01-19 Procedimiento para la produccion de preparados medicinales que contienen y liberan sustancias activas y producto obtenido. MX10146A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873701625 DE3701625A1 (de) 1987-01-21 1987-01-21 Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe

Publications (1)

Publication Number Publication Date
MX10146A true MX10146A (es) 1993-09-01

Family

ID=6319213

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1014688A MX10146A (es) 1987-01-21 1988-01-19 Procedimiento para la produccion de preparados medicinales que contienen y liberan sustancias activas y producto obtenido.

Country Status (14)

Country Link
EP (1) EP0275961B1 (es)
JP (1) JP2744240B2 (es)
KR (1) KR970002615B1 (es)
AT (1) ATE106718T1 (es)
AU (1) AU605824B2 (es)
CA (1) CA1329767C (es)
DE (2) DE3701625A1 (es)
DK (1) DK23588A (es)
FI (1) FI93425C (es)
IL (1) IL85144A (es)
MX (1) MX10146A (es)
NO (1) NO175352C (es)
NZ (1) NZ223228A (es)
ZA (1) ZA88358B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981696A (en) * 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
US4902515A (en) * 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
FR2634770B1 (fr) * 1988-07-29 1990-10-05 Rhone Poulenc Chimie Composition polyester erodable contenant de l'iode pour le traitement des eaux
EP0423484B1 (de) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Pressling mit retardierter Wirkstofffreisetzung
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
DE19500977C2 (de) * 1995-01-14 1999-01-07 Lohmann Therapie Syst Lts Feste Arzneimittelform mit in polymerem Material verteiltem Wirkstoff
DE19908753C2 (de) * 1999-02-20 2003-10-02 Jenapharm Gmbh Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
WO2015184256A2 (en) 2014-05-30 2015-12-03 Shire Human Genetic Therapies, Inc. Biodegradable lipids for delivery of nucleic acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
DE2824112A1 (de) * 1978-06-01 1979-12-06 Garching Instrumente Mikropellets, verfahren zu ihrer herstellung und deren verwendung
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS5966425A (ja) * 1982-10-08 1984-04-14 Mitsui Toatsu Chem Inc 生体分解性重合体を用いた微小粒子の製造方法
FR2557459B1 (fr) * 1984-01-02 1986-05-30 Lhd Lab Hygiene Dietetique Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Also Published As

Publication number Publication date
NO880230L (no) 1988-07-22
FI880210A (fi) 1988-07-22
ATE106718T1 (de) 1994-06-15
IL85144A0 (en) 1988-06-30
FI880210A0 (fi) 1988-01-19
FI93425B (fi) 1994-12-30
AU605824B2 (en) 1991-01-24
DE3889933D1 (de) 1994-07-14
DK23588A (da) 1988-07-22
KR880008806A (ko) 1988-09-13
DK23588D0 (da) 1988-01-20
KR970002615B1 (ko) 1997-03-06
EP0275961A3 (en) 1990-11-22
ZA88358B (en) 1989-09-27
CA1329767C (en) 1994-05-24
NO175352C (no) 1994-10-05
JPS6419025A (en) 1989-01-23
DE3701625A1 (de) 1988-08-04
FI93425C (fi) 1995-04-10
EP0275961B1 (de) 1994-06-08
NZ223228A (en) 1990-12-21
IL85144A (en) 1991-06-30
EP0275961A2 (de) 1988-07-27
AU1065388A (en) 1988-07-28
JP2744240B2 (ja) 1998-04-28
NO175352B (no) 1994-06-27
NO880230D0 (no) 1988-01-20

Similar Documents

Publication Publication Date Title
ATE90570T1 (de) Verbesserte formulierungen mit kontrollierter abgabe.
NO176304C (no) Fremgangsmåte for fremstilling av farmasöytiske implantater på basis av polylaktid
NO921002L (no) Nye estere av tienylkarboksylsyrer og aminoalkoholer, deres kvartaeriseringsprodukter, og fremstilling og anvendelseav forbindelsene
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
AU2840789A (en) Continuous release pharmaceutical compositions
HUT44937A (en) Process for producing pharmaceuticals comprising dipyridamole or mopidamole and o-acetyl-salicylic acid, resp. the salts thereof
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
MX10146A (es) Procedimiento para la produccion de preparados medicinales que contienen y liberan sustancias activas y producto obtenido.
MX10059A (es) Procedimiento para la preparacion de antagonistas de leucotrienos novedosos y producto obtenido
OA08544A (fr) Procédé continu de préparation d'acide phosphorique et de calcium.
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
MX19242A (es) Derivados del acido 2,2-dimetil-3-(2-monohalogenoetenil)-coclopropano-carboxilico, su procedimiento de preparacion y su aplicacion como medicamento.
HU912169D0 (en) Process for the production of 3,3'-ditio-bis(propionic acid)-derivatives and esthers, and medical preparations containing them
FR2692263B1 (fr) Procédé de préparation d'esters cycliques d'acides-alpha-hydroxycarboxyliques.
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
YU196488A (en) Process for obtaining oral formulation for controlled and extended releasing of bispirone and its salts
SE8902603D0 (sv) (rs)-2-(2,3-dihydro-5-hydroxi-4,6,7-trimetylbensofuranyl) aettiksyror och 2-(2,3-dihydro-5-acyloxi-4,6,7-trimetylbensofuranyl) aettiksyror och estrar daerav, anvaendbara saasom slemreglerande och antiischemiska laekemedeloch foerfarande foer framstaellning daerav
ATE106407T1 (de) Derivate von thiazolidin-4-carbonsäure, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE59205884D1 (de) Verfahren zur Herstellung der racemischen und optisch aktiven 1,2,3,4-Tetrahydroisochinolin-3-carbonsäure sowie deren Vorprodukte
MX9458A (es) Procedimiento para la preparacion de compuestos hidrogenados del acido 1-benzooxacicloalquilpiridincarboxilico, producto obtenido y preparacion farmaceutica que los incluye
MX12203A (es) Procedimiento para la preparacion de 1h-pirazol-1-alcanamidas y producto obtenido.